Bharat Biotech, CSIR look at Bringing mRNA Vaccine Technology to India
The Council of Scientific and Industrial Research and Bharat Biotech International are looking at bringing the messenger RNA platform to India after seeing its successful use in quick development of covid-19 vaccines by US-based Pfizer and Moderna.
- CSIR-Indian Institute of Chemical Technology (CSIR-IICT) will be looking at supplying lipid nanoparticles, which are used to stabilise the drug substance for mRNA vaccines, while Bharat Biotech will manufacture the vaccine.
mRNA Vaccine
- mRNA vaccines are a new type of vaccine to protect against infectious diseases. To trigger an immune response, a mRNA vaccine teaches our cells how to make a protein or ....
Do You Want to Read More?
Subscribe Now
To get access to detailed content
Already a Member? Login here
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material since 2018 of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Science & Technology
- 1 India’s First Prototype Fast Breeder Reactor Set for Commissioning in 2025
- 2 New Material for Efficient Water Desalination
- 3 Google Launches Ironwood: 7th-Generation TPU for AI Workloads
- 4 QpiAI-Indus Quantum Computer
- 5 Blood Test for Cervical Cancer Monitoring
- 6 Neuralink to Implant 'Blindsight' Chip in First Human by 2025
- 7 Brain-Computer Interface to Restore Natural Speech
- 8 Successful Trials of Long-Range Glide Bomb Gaurav
- 9 Indian Army Inducts Indigenous FPV Drones
- 10 India Signs Deal with France for 26 Rafale-Marine Fighter Jets
